ZVRA
ZevraยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ZVRA Profile
Zevra Therapeutics, Inc.
A specialty pharmaceutical company focused on treatments for rare central nervous system, neurodegenerative and lysosomal storage diseases
1180 Celebration Boulevard, Suite 103, Celebration, FL 34747
--
Zevra Therapeutics, Inc., was incorporated in Iowa in October 2006 and reorganized in Delaware in May 2014. The company is a rare disease company that combines science, data and patient needs to create translational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapies to people with rare diseases. With a unique, data-driven development and commercialization strategy, the company is overcoming complex drug development challenges to deliver new therapies to the rare disease community. The company has a diverse product portfolio and product candidates that include preclinical development programs, clinical-stage pipelines and commercial-stage assets. The company's team has expertise and a successful track record of advancing promising therapies that face complex clinical and regulatory challenges by balancing science and data with patient needs.
